Congenital absence of the aortic valve is a rare pathology reported mostly as single case reports in the literature. Unlike the congenital absence of the pulmonary valve, the congenital absence of the aortic valve is mostly fatal, resulting in hydrops, foetal demise, or early neonatal death. Reference Qasim, Johnson and Aly1,Reference Yu, Li and Luo2 The absence of the aortic valve is mainly characterised by the absence of aortic valve structure and free regurgitation of the valve, decreased left ventricular functions, a malignant circulation called an inverse circulatory shunt in which severe mitral regurgitation is directed to the right atrium through foramen ovale. We want to demonstrate the images of this rare pathology with the inverse circulatory shunt.
Case presentation
28-year-old nulligravida was evaluated at 30th gestational week. Foetal echocardiography revealed concordant viscera-atrial situs, D-looped ventricles, normally aligned major arteries, and cardiomegaly. The left ventricle was hypoplastic and did not create the apex; the right heart structures were dilated (Fig 1a and b). Mitral annulus was 5.8 mm (z score: −3.36); tricuspid annulus was 9.7 mm (z score: −0.27). The mitral valve was hypoplastic with severe regurgitation and without significant antegrade flow (Fig 1c). There was a massive left to right shunt from the foramen ovale (Video 1). The aortic valve was dysplastic without any visible valve leaflets (Fig. 1d). Severe aortic regurgitation with the minimal antegrade flow and ascending aorta filling by retrograde ductal flow were observed (Fig 2, Video 2). There was a decrease in a wave velocity of ductus venosus flow, and umbilical artery diastolic flow was also decreased. This severe CHD caused severe heart failure; pericardial, pleural effusions, and ascites were developed, and the fetus died in utero at 33rd gestational week.
Discussion
Congenital absence of the aortic valve is a rare anomaly with high mortality. Although mostly fatal cases with hydrops were presented in the literature, rare cases reported by Harada, Krasemann, and Qasim et al, who were born alive without hydrops and operated, were also reported. Reference Qasim, Johnson and Aly1,Reference Harada, Takeuchi and Satomi3,Reference Krasemann, Kehl and Hammel4 Usually, two different haemodynamic presentations with different clinical outcomes were reported about the congenital absence of the aortic valve. Reference Yu, Li and Luo2,Reference Bierman, Yeh and Swersky5 One of them is associated with mitral regurgitation and non-restrictive foramen ovale, which generally causes severe hydrops and intrauterine foetal death. Mitral regurgitation causes “inverse circulatory shunt,” that is, the regurgitation from the ascending aorta to the left ventricle – left atrium by mitral regurgitation – right atrium through the foramen ovale – right ventricle – pulmonary artery – ductus arteriosus and ascending aorta again. Reference Murakami, Lin and Ishiodori6 The other presentation is the absence of the aortic valve with mitral atresia or restrictive foramen ovale, which plays a role in blocking the “inverse circulatory shunt” and the hydrops that enable the fetus to reach the term. Reference Murakami, Horigome and Shiono7,Reference Goltz, Lunkenheimer and Abedini8 But in our case, the fetus with absence of the aortic valve and hypoplastic left ventricle developed hydrops due to the circular shunt consisting of the aortic regurgitation, severe mitral regurgitation, and large left to right shunt through foramen ovale. This made us think that mitral regurgitation can be more essential in the foetal malignant circulation than the morphology of the left ventricle.
In conclusion, the degree of aortic and mitral regurgitation and the flow through the foramen ovale and the ventricular functions evaluated with foetal echocardiography seems valuable for predicting pre- and postnatal outcomes and counselling patient’s pregnancy outcomes. These echocardiographic evaluations are also necessary for planning potential intrauterine treatment, the timing of birth, and postnatal interventions.
Supplementary material
To view supplementary material for this article, please visit https://doi.org/10.1017/S1047951122000919
Acknowledgements
None.
Financial support
None.
Conflict of interest
None.
Ethical standards
The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national guidelines on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008, and have been approved by the institutional committees.